This study was performed to define the 5 year clinical status of 427 patients who underwent percutaneous transluminal coronary angioplasty (PTCA) in 1981. Their mean age was 54 + 10 years (±+ 1 SD). Sixty-one percent had unstable angina, 23% had prior myocardial infarction, 86% had one-vessel disease, and 92% had normal left ventricular function. Sixty-seven percent of patients had left anterior descending artery stenosis. Angiographic success was achieved in 84% of patients. Coronarybypass surgerywas required in 9.6% of patients, in 5.9% as an emergencyprocedure. There were no in-hospital deaths. Follow-up at 5 years was 100% complete. There were 15 late deaths (96.3 ± 1.0% survival), including seven of cardiac cause (98.1 ± 0.7% cardiac survival). Myocardial infarction occurred in 24 patients (94% freedom from myocardial infarction), coronary bypass surgery was required in 63 (84% freedom from bypass surgery), and 365 patients (85%) were asymptomatic at follow-up. At 5 years, 83 patients (20%) had required an additional PTCA. Unstable angina pectoris and proximal left anterior descending coronary artery stenoses were present in 162 patients. The overall survival and cardiac survival in this subset was 94.4 ± 1.8% and 98.1 ± 1.1%, respectively. The excellent survival and low event rates over 5 years in this population support the concept that PTCA is safe and effective for patients with symptomatic angina pectoris, single-vessel disease, and normal left ventricular function.
in most centers, during the early PTCA learning curve. In the initial NHLBI series, less than two-thirds of PTCA attempts were successful. 11 This study was undertaken to determine the late clinical outcome at 5 years in a large series of consecutive patients who underwent PTCA at Emory University Hospital in 1981, a period in which success rates were comparable to those now achieved by most PTCA operators.
Methods
Patients. In 1981, 427 patients underwent attempted PTCA at Emory University Hospital. Their mean age was 54 + 10 years (range 29 to 78), and 330 (77%) were men (table 1) . Unstable angina pectoris, defined as a change in the frequency, intensity, or pattern of precipitating events, within the preceding 60 days was present in 260 patients (61%). Stable angina pectoris was present in 130 patients. Seventeen patients did not have angina pectoris and the information regarding anginal status was either unknown or ambiguous in 20 . Of those patients with unstable angina, 127 had the onset of symptoms within 60 days of the PTCA, 39 had progressive angina, 59 had angina at rest, and 35 had myocardial ischemia lasting greater than 20 min. Angina was classified according to the characteristics outlined by the Canadian Cardiovascular Society.'2 In the group of CIRCULATION Single-vessel disease, defined as a 50% or greater diameter stenosis in the left anterior descending, left circumflex, or right coronary artery or in the major branch or branches of one of these three major epicardial arteries, was present in 369 patients (86.4%). Mean diameter stenosis of all lesions (average of two near orthogonal views) was 72 + 14%. Single-vessel left anterior descending artery stenosis was present in 267 patients (63%), with the lesion defined as a proximal stenosis (before the first major septal or diagonal branch) in 248 patients (58%). Single-vessel left circumflex artery stenoses were present in 16 patients (4%), and right coronary artery stenoses were present in 86 patients (23%). Multivessel coronary artery disease was present in 58 patients (14%), two-vessel disease in 40 patients, three-vessel disease in 14 patients, and left main disease in four patients.
Calculated or estimated left ventricular ejection fraction data were available for 413 patients (97%); the mean ejection fraction in these patients was 64 + 9%. Ninety-five percent of these patients had ejection fractions greater than or equal to 50%. A total of 451 lesions were dilated in the 427 patients. In a subset of patients with proximal left anterior descending involvement and unstable angina, 162 lesions were dilated (36% of the total population).
Vol. 77, No. 4, April 1988 PTCA technique. All procedures were performed by three operators using a standard technique that has previously been described in detail.'3 Procedures were done by the femoral approach after sedation with 5 to 10 mg IV diazepam. Patients received 325 mg aspirin orally the night before the procedure and 40 g dextran and 10,000 to 20,000 U IV heparin during the procedure. Nifedipine (10 mg sublingual) and atropine (0.4 mg IV) were administered before the procedure. Dilatation was attempted with type G, DG, and DJ balloon catheters (USCI Inc., Billerica, MA). Patients were treated after the procedure with 325 mg aspirin daily and 10 mg nifedipine in four doses daily and were discharged after 2 to 3 days on these medications.
Pre-and post-PTCA angiograms were examined by experienced angiographers. The minimal luminal diameter of each lesion was measured by angiographers but not the PTCA operator in multiple views as a percentage of the normal arterial segment, and the result was expressed as the mean percent diameter narrowing of two available views.
Angiographic success was defined as a residual obstruction of less than 50% in all sites attempted. Clinical success was defined as the achievement of angiographic success without the need for subsequent in-hospital emergency or elective CABG or the occurrence of myocardial infarction (presence of new Q waves . 40 msec or creatine kinase 2 510 U with any MB fraction). Emergency CABG was defined as CABG performed in the same or subsequent days for unstable or ongo g myocardial ischemia or because of the presence of severe intimal dissection or a severe residual lesion "threatening" imminent closure of the instrumented vessel. Elective CABGwas defined as CABG performed in patients with an angiographically unsuccessful PTCA who did not have ongoing myocardial ischemia or "threatening" anatomic signs. 821
Data collection and patient follow-up. Baseline demographic, clinical, angiographic, and procedural data, including complications, were recorded prospectively by physicians on standard forms and entered into a computerized data base. Follow-up was obtained by telephone interviews with patients or their referring physicians in 1986. The trained interviewers had no knowledge of the success of or complications associated with the initial procedure. Follow-up information included current angina pectoris status, history of myocardial infarction since the initial PTCA, need for additional revascularization procedure (PTCA or CABG), and death (cardiac or noncardiac). All information was recorded on standard forms and entered into the computerized data base. Follow-up was 100% complete. Data analysis. Continuous variables are presented as mean + 1 SD and were analyzed by unpaired t tests. Categorical variables were compared by chi-square analysis or Fisher's exact test. Analysis of overall survival and event-free survival was performed by the Kaplan-Meier method`4 and probability was expressed as mean + SEM. Overall survival and event-free survival analyses were performed on data from the total populations of patients, those with singleand multiple-vessel disease, those with stenosis of the proximal left anterior descending coronary artery, and those with unstable angina pectoris undergoing PTCA to proximal stenoses of the left anterior descending coronary artery. In each case, analyses were performed for the entire population and for the subset of patients with clinically successful procedures. End points analyzed included total survival and cardiac survival, survival without myocardial infarction, and survival without myocardial infarction, CABG, or cardiac death. Comparisons of total survival and event-free survival were made by the Mantel-Cox method.15' 16 All tests were done with BMDP statistical software (BMDP Statistical Software, Inc., Los Angeles).
Results
Initial results. For the total population, attempted dilatation was unsuccessful in 67 patients (16%), resulting in angiographic success in 360 patients (84%) (table 2). An additional 22 patients (5.2%) had a technically successful procedure but there was a complication. Emergency (5.9%) or elective (3.7%) CABG was performed in 41 patients (9.6%). Myocardial infarction, defined as a creatine kinase elevation three times the upper limit of normal and any MB fraction, occurred in 23 patients (5.4%) and in nine patients (2.1%) was associated with the development of a new Q wave. There were no in-hospital deaths. Repeat PTCA was required during initial hospitalization for acute closure or incomplete dilatation in eight patients. Mean diameter stenosis after the procedure in successfully treated patients was 27% (range 1% to 49%). The procedure was angiographically and clinically successful in 338 patients (79.2%).
Angiographic and clinical success was achieved in 295 of 369 patients (79.9%) with single-vessel disease and in 43 of 58 patients (74.1%) with multivessel disease (table 2). Emergency CABG was required in 21 patients (5.7%) with single-vessel disease and four patients (6.9%) with multivessel disease. Elective CABG was performed in 16 patients, 15 with singlevessel disease and one with multivessel disease. There were seven (1.9%) Q-wave myocardial infarctions in patients with single-vessel disease and two (3.4%) in patients with multivessel disease. Table 3 analyzes the complications in patients with a clinically unsuccessful PTCA. Myocardial infarction occurred in 14 of 41 patients (34%) who underwent surgery for failed PTCA and in nine of 48 patients (18.8%) with failed angioplasty not requiring surgery (p < .01). Seven of the 14 patients undergoing CABG and two of the nine patients treated medically had a Q-wave myocardial infarction.
In patients with disease involving the proximal left anterior descending coronary artery, angiographic success was achieved in 237 (89.4%, table 4). CABG or myocardial infarction occurred in 13 patients after an initially successful procedure, resulting in a clinical success in 224 patients (84.5%).
Late results. Survival at 5 years for the total population was 96.3% (table 5 ). There were 15 deaths of Overall survival at 5 years for the 338 patients who had a clinically successful procedure was 96.8% (table  5 ). There were 10 deaths, seven noncardiac and three cardiac, so that cardiac survival was 98.8% (figure 2). Myocardial infarction occurred during follow-up in 19 patients. Freedom from cardiac death or myocardial infarction over 5 years was 92.8%. An additional PTCA procedure was required within 6 months in 43 patients (12.8%), within 12 months in 63 patients (18.7%), and in a total of 74 patients (22.9%) during the follow-up period. Forty-two patients (13.5%) required CABG during the follow-up period. At 5 years, 81.7% of clinically successful PTCA patients were free from cardiac death, myocardial infarction and CABG.
Cardiac survival at 5 years (96.5% vs 94.8%) was not significantly different between patients with single- 
. Five year cumulative survival and event-free survival rates in 338 patients undergoing clinically successful PTCA. End points are as described in figure 1. vessel vs multivessel disease. There was a trend for improved freedom from cardiac death, myocardial infarction, and CABG (figure 3) in patients with singlevessel vs multivessel disease (80% vs 71%; p = NS), but the number of patients in the latter group was small. Stenoses of the proximal left anterior descending artery before its first major branch occurred in 265 patients. In 248 patients, this was the only significant ( 
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disease while in 17 patients there was significant disease in other vessels. Overall survival at 5 years for the entire group was 95.8% (table 5) . Cardiac survival was 98.5% (figure 4) at 5 years; 79% of patients were free of cardiac death, myocardial infarction, and CABG.
In the subset of 162 patients with unstable angina pectoris and proximal left anterior descending stenoses, clinical success was achieved in 136 (84%). Over-all survival at 5 years was 94.4%. There were nine deaths, including three of cardiac causes. Cardiac survival at 5 years was 98% ( figure 5 ). At 5 years, 81% were free of cardiac death, myocardial infarction, and CABG. Eighty-three percent remained asymptomatic at last follow-up.
Discussion
This study examines the late clinical outcome in a consecutive series of patients who underwent attempted PTCA in 1981. It is important to consider late results not only in terms of the total population of patients undergoing PTCA but also in terms of patients with successful procedures. Despite the early period in which these procedures were performed, the clinical success rate (79%) is comparable to that currently achieved in many centers. However, with currently available equipment, it is expected that initial success rates with similar patients should be 10% to 15% higher at experienced centers. 17 In contrast to initial success rates, restenosis rates have changed little since 1981. Thus the data on late clinical outcome after successful PTCA should be applicable to current practice.
Survival was excellent for both the total population and for those patients with successful procedures. The survival statistics are significantly affected by the absence of any mortality associated with an initial revascularization attempt. This emphasizes the safety of PTCA in suitable candidates when performed at experienced centers with skilled anesthesia and cardiothoracic surgical staff. Excellent survival at 5 years, however, might have been expected in many of these patients regardless of the success of the PTCA procedure because most of them had single-vessel disease and good left ventricular function, features known to affect survival in a favorable manner. In addition, a large percentage of the patients with unsuccessful PTCA had elective surgical revascularization either during the same hospital admission or within the following 6 months. However, compared with medical therapy, the influence of revascularization has never been adequately studied in a similar population of symptomatic patients, almost all of whom were con-826 sidered surgical candidates. The Veterans Administration Cooperative Study18 excluded patients with unstable angina and myocardial infarction within the previous 6 months, the European Coronary Surgery Study19 excluded patients with single-vessel disease, and the Coronary Artery Surgery Study (CASS)20 excluded patients with severe (greater than CCS class II) or unstable angina pectoris. Therefore, the survival of patients similar to those in this series treated medically cannot be predicted from the results of these previous studies.
The number of diseased coronary arteries is an important prognostic descriptor in patients with coronary artery disease treated medically21-23 and with CABG,20 and some data suggest this is true for patients treated with PTCA.4' 10 In Gruentzig's initial series,10 long-term cardiac mortality in the patients with multivessel disease was more than twice that in patients with single-vessel disease. In the present study, there was a trend toward less favorable survival for patients with multivessel disease, although the population was too small to draw definite conclusions.
The majority of patients in the present study had symptomatic, single-vessel coronary artery disease and the long-term results in this large series provide a unique opportunity to consider the potential benefit of PTCA when used as the initial therapeutic option in such patients. The hazards in making comparisons with similar groups of patients treated with other therapies are well recognized. Prognostically important baseline descriptors cannot be accurately equated, selection criteria cannot be satisfactorily defined, and therapeutic and experimental environments almost certainly differ between different prospective studies, institutions, and time periods. However, the cardiac mortality in the 369 patients with single-vessel disease in the present study deserves some further considerations. Most had proximal lesions jeopardizing a significant area of myocardium, 67% had proximal left anterior descending artery stenoses, and the great majority had grade III or IV stable angina or had unstable angina pectoris. Among patients assigned to medical therapy in the CASS,20 none had grade III or IV or unstable angina and only 30% had proximal stenoses of the proximal left anterior descending artery. Despite these differences, 5 year mortality in medically assigned patients in the CASS with singlevessel disease and normal left ventricular function was 5%, compared with 3.5% in the present study. In patients with single-vessel disease entered in the CASS Registry21 and treated medically, 5 year mortality was 10%; in patients with proximal single-vessel disease, Since mortality in patients with single-vessel disease is so low, it may be difficult to detect a beneficial effect of any intervention during a 5 year follow-up period. In contrast, myocardial infarction in patients with single-vessel disease does occur. Nonfatal myocardial infarction or cardiac death has been reported in 20% of patients with single-vessel disease at 5 years,24 and in the previously cited study25 of potential PTCA candidates with single-vessel disease treated medically 15% had myocardial infarction or death at 5 years. In the present study, patients with single-vessel disease had a 7% incidence of myocardial infarction or cardiac death at 5 years.
Coronary artery disease is frequently a progressive condition, and survival in patients with single-vessel disease has been shown to decline significantly at about 5 years after initial angiographic documentation. 23 This decline is thought to be related to both progression of disease and probably deterioration in left ventricular function from subsequent myocardial infarction. Once left ventricular function is impaired, prognosis deteriorates even in patients with single-vessel disease. 22 Thirteen patients in the present study underwent an additional PTCA and another 19 patients had CABG more than 12 months after the initial procedure, most commonly for disease progression.
Prognosis in coronary artery disease is also closely related to the amount of myocardium in jeopardy.2'
Lesions in the proximal left anterior descending coronary artery place a large area of myocardium at risk, and there exists a large body of evidence that supports the detrimental prognostic influence of such lesions.26-28 New-onset and "preinfarction" angina is also associated with increased risk of myocardial infarction and death.29 To evaluate further the possible favorable influence of PTCA on prognosis, this study examined outcome in a large subset of patients with both proximal left anterior descending artery stenoses and unstable angina pectoris. In these 162 patients there were only seven myocardial infarctions and three cardiac deaths. Cardiac mortality at 5 years was 1.9%, and either myocardial infarction or cardiac death occurred in only 7%. These data contrast markedly with outcomes previously reported. Califf et al.24 reported a 828 10% mortality at 5 years in patients with proximal left anterior descending disease treated medically. In another study from the same institution25 on potential PTCA candidates treated medically, all deaths occurred in the subset of patients with left anterior descending disease. Such comparisons must be considered with caution because baseline variables cannot be compared and factors such as left ventricular function almost certainly influence outcome. Overall left ventricular function in the patients with proximal left anterior descending disease in this study was good and this outweighed the presence of unstable symptoms, which would most likely have increased the risk associated with these lesions had the patients been treated medically.22
Finally, it is clear from the present study that longterm relief of angina pectoris can be achieved by PTCA as an initial treatment modality. Such a course must include the possibility of repeat procedures, PTCA or CABG, for restenosis and disease progression. Over 90% of our patients were symptomatic at the time of their procedure and only 15% were symptomatic at 5 years. Angina pectoris, however, is difficult to quantify in large population studies and can be influenced by many factors, including the amount of exercise activity, antianginal medications taken, and placebo effect. To achieve these apparently favorable results, a significant number of patients (29.7%) required additional revascularization procedures (10.3% CABG, 15% PTCA, and 4.4% both). This deserves comment. In 1981 PTCA was not capable of achieving effective revascularization in an important percentage of patients, and most of these patients were referred to elective or emergency surgery. At that time, the efficacy of repeat PTCA30' 31 had not been clearly established. Even so, almost 80% of patients have been free of cardiac death and myocardial infarction without the need for CABG. A significant number of these patients required repeat PTCA for restenosis.
Conclusion. This complete 5 year follow-up of patients selected as good candidates for PTCA demonstrates excellent survival, improvement in symptoms, and freedom from myocardial infarction. These results cannot be extended to other subsets of patients with coronary artery disease, in whom randomized trials will be necessary to prove the true value of PTCA by wider application of the technique.
